Health & Safety Industry Today
Ablation Device Market Set to Reach USD 13.20 Billion by 2030 Driven by Minimally Invasive Procedures and PFA Uptake
Introduction
The ablation device market is witnessing robust growth as healthcare providers increasingly favor minimally invasive, energy-based treatment methods across cardiology, oncology, and other specialties. According to Mordor Intelligence, the market was valued at USD 8.05 billion in 2025 and is projected to reach USD 13.20 billion by 2030, registering a CAGR of 10.41%. Rising incidences of chronic diseases and the aging population are key demand drivers. The shift toward outpatient and same-day procedures further enhances market expansion. Emerging technologies like pulsed-field ablation (PFA) are gaining attention due to their precision and reduced risk. Although radiofrequency ablation remains dominant, non-thermal ablation platforms are increasingly adopted. North America currently leads in revenue, while Asia-Pacific is expected to grow fastest, supported by improving healthcare infrastructure and increasing awareness of minimally invasive solutions.
Key Trends
- Rapid Commercial Adoption of PFA Systems
- Technological Advancements in Ablation Devices
- Surge in Demand for Minimally Invasive Procedures
- Growing Incidence of Atrial Fibrillation
- Reimbursement Uncertainty for Novel Energy Modalities
- High Cost of Ablation Devices & Disposables
Check out more details and stay updated with the latest industry trends, including the Japanese version for localized insights:
Market Segmentation
By Device Technology
- Radiofrequency (RF)
- Cryoablation
- Microwave
- Laser / Light
- Ultrasound / HIFU
- Pulsed-Field (PFA)
- Others
By Application
- Oncology
- Cardiovascular Disease
- Ophthalmology
- Gynecology
- Urology
- Cosmetic & Dermatology
- Pain Management & Neurology
By End-User
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Specialty & Cancer Centers
By Mode of Procedure
- Percutaneous
- Laparoscopic
- Open / Surgical
Geography Analysis
North America continues to hold a strong position in the global ablation device landscape, supported by a well-structured healthcare system, favorable reimbursement policies, and rapid clinical adoption of advanced technologies. The region’s emphasis on clinical research and early regulatory clearances keeps it at the forefront of innovation, ensuring widespread confidence among healthcare providers.
Explore Our Full Library of Healthcare Research Industry Reports - https://www.mordorintelligence.com/market-analysis/healthcare?utm_source=Industrytoday.co.uk
Key Players
The report identifies Medtronic PLC, Johnson & Johnson, Abbott Laboratories, Boston Scientific Corporation and AngioDynamics, Inc. as the major companies active in the ablation‐devices market. These firms compete in technologies such as radiofrequency, cryoablation and emerging pulsed‐field ablation, and are distinguished by broad geographic reach, strong R&D investment and ability to serve both cardiovascular and oncology ablation applications.
Trending Reports
About Mordor Intelligence:
Mordor Intelligence is a trusted partner for businesses seeking actionable market insights. With 550+ domain experts and specialists across 150+ countries, we deliver comprehensive syndicated and custom research across industries such as aerospace, agriculture, chemicals, consumer goods, energy, healthcare, and many more, helping organizations make informed decisions and achieve strategic goals.
For any inquiries or to access the full report, please contact:
https://www.mordorintelligence.com/
Share on Social Media
Other Industry News
Ready to start publishing
Sign Up today!
